Research progress of mesenchymal stem cells in female reproductive medicine.
10.3760/cma.j.cn112150-20220110-00033
- VernacularTitle:间充质干细胞在女性生殖医学领域的研究进展
- Author:
Jing ZHAO
1
;
Han Bi WANG
2
;
Chengyan DENG
2
Author Information
1. Department of Reproductive Medicine, Fuyang People's Hospital, Fuyang 236000, China.
2. Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Gynecology and Obstetrics, State Key Laboratory of Difficult Severe and Rare Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Female;
Mesenchymal Stem Cell Transplantation;
Mesenchymal Stem Cells;
Regenerative Medicine;
Signal Transduction
- From:
Chinese Journal of Preventive Medicine
2022;56(12):1709-1715
- CountryChina
- Language:Chinese
-
Abstract:
Stem cells have been a hot spot in medical research for a long time and have unique advantages in tissue repair, diagnosis and treatment of diseases. With the development of regenerative medicine, stem cells have been widely studied and applied in reproductive medicine, such as improving ovarian function and repairing endometrial damage. These efforts are achieved primarily through the use of mesenchymal stem cells(MSCs) from a variety of sources. However, the application of stem cells also faces problems such as low cell retention rate and medical ethics. This article focuses on the research progress and clinical application of MSCs (not involving embryonic stem cells) in the field of female reproductive medicine.
